We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+34.87%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$11.6B
AUM Growth
+$2.27B
(+24%)
Cap. Flow
-$278M
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
30.23%
Holding
354
New
65
Increased
75
Reduced
125
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$106M |
| 2 |
Meta Platforms (Facebook)
META
|
+$106M |
| 3 |
PayPal
PYPL
|
+$105M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$99.5M |
| 5 |
Ciena
CIEN
|
+$86.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$85.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$84.6M |
| 3 |
Amazon
AMZN
|
+$72.7M |
| 4 |
Intel
INTC
|
+$72.2M |
| 5 |
RingCentral
RNG
|
+$71.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Healthcare | 19.11% |
| 3 | Financials | 17.15% |
| 4 | Communication Services | 12.94% |
| 5 | Consumer Discretionary | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.84T
| $684M | 5.9% |
3,360,645
+37,178
| +1% | +$6.75M |
|
2
Apple
AAPL
$4.89T
| $546M | 4.72% |
5,991,328
+880,304
| +17% | +$68.2M |
|
|
3
Meta Platforms (Facebook)
META
$1.51T
| $352M | 3.04% |
1,549,311
+508,267
| +49% | +$106M |
|
|
4
Amazon
AMZN
$2.5T
| $350M | 3.02% |
2,535,000
-601,600
| -19% | -$72.7M |
|
5
Alphabet (Google) Class C
GOOG
$3.9T
| $306M | 2.64% |
4,326,360
+275,180
| +7% | +$18.6M |
|
6
Alibaba
BABA
$269B
| $295M | 2.55% |
1,367,575
-126,717
| -8% | -$26.4M |
|
|
7
PayPal
PYPL
$49.5B
| $263M | 2.27% |
1,509,424
+760,919
| +102% | +$105M |
|
|
8
Alphabet (Google) Class A
GOOGL
$3.91T
| $257M | 2.22% |
3,624,960
+282,760
| +8% | +$19.1M |
|
9
Advanced Micro Devices
AMD
$851B
| $250M | 2.16% |
4,750,625
+161,763
| +4% | +$8.58M |
|
10
Adobe
ADBE
$89.5B
| $199M | 1.72% |
458,019
+191,118
| +72% | +$70.8M |
|
11
NVIDIA
NVDA
$5.01T
| $193M | 1.67% |
20,354,560
-2,444,360
| -11% | -$19.8M |
|
12
ServiceNow
NOW
$102B
| $162M | 1.4% |
2,000,095
+657,225
| +49% | +$46.4M |
|
13
Netflix
NFLX
$292B
| $155M | 1.34% |
3,412,010
+858,460
| +34% | +$36.5M |
|
|
MRSH
14
Marsh
MRSH
$86.3B
| $155M | 1.34% |
1,445,721
-501,854
| -26% | -$50.8M |
|
15
Arch Capital
ACGL
$36.1B
| $155M | 1.34% |
5,402,423
-462,520
| -8% | -$12.8M |
|
|
16
UnitedHealth
UNH
$382B
| $144M | 1.25% |
489,399
+371,667
| +316% | +$106M |
|
17
Visa
V
$677B
| $132M | 1.14% |
683,984
-51,697
| -7% | -$9.44M |
|
|
EVBG
18
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $131M | 1.13% |
947,599
+295,686
| +45% | +$38.4M |
|
|
XLNX
19
DELISTED
Xilinx Inc
XLNX
| $127M | 1.09% |
1,287,691
+1,122,437
| +679% | +$99.5M |
|
20
Chubb
CB
$140B
| $127M | 1.09% |
999,887
-192,168
| -16% | -$22.3M |
|
|
ZEN
21
DELISTED
ZENDESK INC
ZEN
| $106M | 0.91% |
1,196,796
+188,220
| +19% | +$14.5M |
|
22
Markel Group
MKL
$25B
| $103M | 0.89% |
111,357
-4,200
| -4% | -$3.82M |
|
23
Salesforce
CRM
$134B
| $102M | 0.88% |
544,007
-213,565
| -28% | -$36M |
|
24
Mastercard
MA
$477B
| $99.6M | 0.86% |
336,713
+34,847
| +12% | +$9.82M |
|
25
Regeneron Pharmaceuticals
REGN
$68.8B
| $99.4M | 0.86% |
159,440
+109,440
| +219% | +$62.1M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Polar Capital held 354 positions worth $11.6B, up 24% from $9.31B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Polar Capital's Q2 2020 filing shows 65 new, 75 increased, 125 reduced and 74 closed positions. Its largest new stake was TripAdvisor: 3,886,053 shares worth $73.9M. The largest sale was AbbVie, an estimated $85.6M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.
- Polar Capital's largest Q2 2020 buy was TripAdvisor: 3,886,053 shares worth $73.9M.
- Polar Capital added most to UnitedHealth in Q2 2020, an estimated $106M increase.
- Polar Capital's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $84.6M.
- Polar Capital fully exited AbbVie in Q2 2020, selling an estimated $85.6M.
- Polar Capital's ten largest holdings make up 30% of its $11.6B portfolio in Q2 2020.
- Polar Capital opened 65 new positions and closed 74 in Q2 2020.
- Polar Capital's portfolio value rose 24% quarter-over-quarter to $11.6B.
Based on Polar Capital's 13F filing for Q2 2020, filed 14 Aug 2020.